ALEXANDRA BRONIS: Open Payments
NPI 1699444869 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 15 payments from 7 companies in 2025. Trend: 2023 $48 · 2024 $343 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 7 | $161 |
| Novo Nordisk Inc | 2 | $56 |
| Actelion Pharmaceuticals US, Inc. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Davol Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: AMVUTTRA, Wegovy, OPSUMIT, Kerendia, VERQUVO, Phasix Mesh, NEXLETOL.
Industry payments across NY — which companies pay providers there.
